Cerebral Small Vessel Diseases: Clinical Trials

512 trials for Cerebral Small Vessel Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

209 completed, 100 recruiting, 93 unknown, 35 terminated. 84 Not applicable, 83 Phase 2, 58 Phase 3, 35 Phase 1, 33 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable84Completed 30, Unknown 20, Recruiting 13, Not yet recruiting 8, Terminated 6, Active not recruiting 5, Enrolling by invitation 1, Withdrawn 1
Phase 283Completed 40, Terminated 12, Active not recruiting 7, Recruiting 7, Unknown 7, Not yet recruiting 4, Withdrawn 4, Enrolling by invitation 1, Suspended 1
Phase 358Completed 35, Terminated 8, Recruiting 7, Active not recruiting 3, Not yet recruiting 2, Unknown 2, Withdrawn 1
Phase 135Completed 20, Recruiting 5, Terminated 4, Active not recruiting 3, Not yet recruiting 2, Withdrawn 1
Phase 433Completed 12, Unknown 9, Not yet recruiting 4, Recruiting 4, Terminated 2, Withdrawn 2
Early Phase 14Completed 3, Recruiting 1

Follow Cerebral Small Vessel Diseases: new trials by email Literature Review of Cerebral Small Vessel Diseases trials Research Report on Cerebral Small Vessel Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
Glycerol Tributyrate - MELAS Syndrome, Lebers Hereditory Optic Neuropathy With Extra Ocular Symptoms (LHON-Plus)
Phase 1 / Phase 2Not yet recruitingGeorge Washington University242027-03-012026-10-05
Study on Eye-Brain Cross-Organ Mapping and Systemic Disease Association Based on Multimodal Big Data
No interventions were involved in this study. - Cataract, Vitreous Hemorrhage
Not yet recruitingBeijing Friendship Hospital2080002026-12-252026-10-16
A Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry Disease
Lucerastat - Fabry Disease
Phase 3RecruitingIdorsia Pharmaceuticals Ltd.162026-12-012026-11-03
Continuous Blood Pressure Variability and Small Vessel Disease in Acute Ischemic Stroke
Cuffless ring-type continuous blood pressure monitor - Ischemic Stroke, Acute, Blood Pressure Variability
RecruitingMinyoul Baik4502026-11-062026-11-12
Therapeutic Implications of CMR Low Native T1 in Non-treated Non-hypertrophic Females With Fabry Disease (FD)
Decision tree for initiating treatment - Fabry Disease
Not applicableNot yet recruitingUniversity Hospital, Bordeaux602026-11-012026-10-14
Outcome Prediction and Recovery After Spontaneous Intracerebral Haemorrhage
Intracerebral Hemorrhage, Hemorrhagic Stroke
Not yet recruitingUniversity Medical Centre Maribor3002026-11-012026-10-20
Personalized Intermittent Theta Burst Stimulation for Cognitive Impairment Related to Cerebral Small Vessel Disease
Active Personalized Intermittent Theta Burst Stimulation, Sham Personalized Intermittent Theta Burst Stimulation - Cerebral Small Vessel Disease, Vascular Cognitive Impairment
Not applicableNot yet recruitingXuanwu Hospital, Beijing1602026-10-012026-10-23
Quality of Life in Adults With Untreated Fabry Disease in Sweden (QoLUF)
Qualitative Interview - Fabry Disease
Enrolling by invitationVastra Gotaland Region352026-08-212026-08-27
The Longitudinal Cohort of Cerebral Small Vessel Disease in Ruijin Hospital
Cerebral Small Vessel Disease
Not yet recruitingRuijin Hospital4002026-07-082026-07-24
Safety and Efficacy of Edaravone Dexborneol Sublingual Tablets for Blood-Brain Barrier Dysfunction in CADASIL
Edaravone Dexborneol Sublingual Tablets - CADASIL
Phase 2Not yet recruitingHuashan Hospital602026-07-012026-07-09
Biological Collection of the Rare Diseases of the Brain and Eye Vessels Cohort - 2
Biocollection, Neurological evaluation and Biocollection - CADASIL, Cavernous Angioma
Not applicableNot yet recruitingAssistance Publique - Hôpitaux de Paris6002026-06-302026-06-16
Observational Study on Long-term Use of Pegunigalsidase Alfa in Fabry Patients in a Real-world Setting
pegunigalsidase alfa - Fabry Disease
RecruitingChiesi Italia752026-06-152026-07-08
MRI-Based Lesion Differentiation in Older Patients With Multiple Sclerosis
Multiple Sclerosis (MS), Cerebral Small Vessel Diseases
RecruitingOslo University Hospital10002026-05-112026-06-01
Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)
Observational assessment - Periodontal Disease, Periodontitis
RecruitingStefan Lujinschi1002026-05-042026-06-26
KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
Sonlicromanol, Placebo - Mitochondrial Diseases, Maternally Inherited Diabetes and Deafness (MIDD)
Phase 3RecruitingKhondrion BV2202026-04-142026-10-14
Remote Ischemic Conditioning for Cognitive Impairment in Cerebral Small Vessel Disease
Remote ischemic conditioning using IPC-906 device, Sham remote ischemic conditioning using IPC-906 device - Cerebral Small Vessel Disease, Cognitive Impairment
Not applicableNot yet recruitingJiangsu Province Nanjing Brain Hospital402026-04-012026-03-10
Care Pathway for Patients With Fabry's Disease (Fabry-PATH)
Self-questionnaire - Fabry Disease
Not yet recruitingUniversity Hospital, Toulouse2002026-04-012026-03-20
Cerebral Small Vessel Disease Progression Dependent on Stroke Type
Cerebral Small Vessel Disease, Stroke
RecruitingJohannes Dorst1802026-03-262026-05-28
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Dengue 1,2,3,4 (attenuated) vaccine - Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA)
Phase 4RecruitingUniversity of Sao Paulo General Hospital4772026-03-162026-07-20
Neural Correlates (EEG and fMRI) of Gait in Small Vessel Disease
No Intervention: Observational - Cerebral Small Vessel Disease
Not yet recruitingAin Shams University402026-03-012026-02-03

Showing 20 of 512. Sign in to see all of them.

Narrower conditions

Fabry Disease (243)  ·  Microscopic Polyangiitis (69)  ·  Granulomatosis with Polyangiitis (62)  ·  Stroke (47)  ·  MELAS Syndrome (37)  ·  CADASIL (33)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (32)  ·  Cognitive Dysfunction (28)  ·  Vasculitis (27)  ·  Churg-Strauss Syndrome (26)  ·  Ischemic Stroke (23)  ·  Mitochondrial Diseases (23)  ·  Stroke, Lacunar (21)  ·  Lysosomal Storage Diseases (18)

Broader conditions

Brain Diseases (510)  ·  Central Nervous System Diseases (509)  ·  Vascular Diseases (507)  ·  Nervous System Diseases (506)  ·  Cardiovascular Diseases (504)  ·  Cerebrovascular Disorders (501)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (323)  ·  Genetic Diseases, Inborn (321)  ·  Nutritional and Metabolic Diseases (293)  ·  Metabolic Diseases (288)  ·  Brain Diseases, Metabolic, Inborn (287)  ·  Brain Diseases, Metabolic (286)  ·  Metabolism, Inborn Errors (286)  ·  Lipid Metabolism, Inborn Errors (247)

Interventions

agalsidase beta (28)  ·  migalastat (28)  ·  agalsidase alfa (24)  ·  larazotide acetate (19)  ·  Rituximab (16)  ·  Azathioprine (10)  ·  Cyclophosphamide (10)  ·  Blood Specimen Collection (8)  ·  Cilostazol (7)  ·  Prednisone (7)  ·  Enzyme Replacement Therapy (5)  ·  Glucocorticoids (5)  ·  Methylprednisolone (5)  ·  Mycophenolic Acid (5)  ·  6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (4)

Sponsors

Amicus Therapeutics (24)  ·  Assistance Publique - Hôpitaux de Paris (20)  ·  Genzyme, a Sanofi Company (17)  ·  Shire (12)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (11)  ·  Beijing Tiantan Hospital (10)  ·  University Hospital, Bordeaux (9)  ·  Chiesi Farmaceutici S.p.A. (8)  ·  University of Pennsylvania (8)  ·  Yonsei University (7)  ·  CENTOGENE GmbH Rostock (6)  ·  Khondrion BV (6)  ·  Protalix (6)  ·  Sanofi (6)  ·  Cambridge University Hospitals NHS Foundation Trust (5)

Countries

United States (160)  ·  United Kingdom (90)  ·  France (79)  ·  China (70)  ·  Canada (55)  ·  Germany (51)  ·  Italy (51)  ·  Australia (39)  ·  Spain (33)  ·  Netherlands (30)  ·  Denmark (29)  ·  Poland (25)  ·  Czechia (24)  ·  Belgium (22)  ·  Japan (22)

Top investigators

Peter A. Merkel, MD, MPH (7)  ·  Nieto Luis, Master (6)  ·  Michio Hirano, MD (5)  ·  Peter A Merkel, MD, MPH (5)  ·  Amanda M. Terry, MA (3)  ·  Arndt Rolfs, MD (3)  ·  Loic Guillevin, MD, PhD (3)  ·  Ozlem Goker-Alpan, MD (3)  ·  Peter Merkel, MD, MPH (3)

Results publications

PMID 27657681, PMID 25795794, PMID 27509102, PMID 39847314, PMID 23176611, PMID 23726159, PMID 23867200, PMID 28592297, PMID 31889231, PMID 32994552, PMID 33164993, PMID 34061144, PMID 35833913, PMID 36481125, PMID 37652700, PMID 10356105, PMID 10665494, PMID 11386930, PMID 11786196, PMID 14762035, PMID 15100373, PMID 15110037, PMID 15229130, PMID 15364702, PMID 17179052, PMID 17531269, PMID 17656478, PMID 18346516, PMID 19054820, PMID 19109574, PMID 19150871, PMID 19451574, PMID 19515805, PMID 19933977, PMID 20075087, PMID 20093349, PMID 20167921, PMID 20386637, PMID 20446946, PMID 20610345, PMID 20647199, PMID 20688574, PMID 20730727, PMID 21060104, PMID 21196729, PMID 21371282, PMID 21778438, PMID 21899409, PMID 21954229, PMID 22133740

NIH funding

2009 (4), 2018 (4), U54AR057319 (4), 2016 (3), 2019 (3), 2023 (3), U54NS065768 (3), U54NS078059 (3), 2014 (2), 2015 (2), 2017 (2), P01HD032062 (2), 1RF1AG074608-01 (1), 2025 (1), R01HD073292 (1)